Health effects with consumption of the flax lignan secoisolariciresinol diglucoside

British Journal of Nutrition

Volumn 103, Issue 7, 2010, Pages 929-938

  Adolphe, Jennifer L ^a   Whiting, Susan J ^a   Juurlink, Bernhard H J ^b   Thorpe, Lilian U ^c   Alcorn, Jane ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b ALFAISAL UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Flax lignans; Health benefits; Secoisolariciresinol diglucoside

Indexed keywords

ENTERODIOL; ENTEROLACTONE; LIGNAN; LIGNAN DERIVATIVE; LINOLENIC ACID; PLACEBO; SECOISOLARICIRESINOL; SECOISOLARICIRESINOL DIGLUCOSE; UNCLASSIFIED DRUG; ANTIOXIDANT; BUTANEDIOL; ENZYME ACTIVATOR; ENZYME INHIBITOR; GLUCOSIDE; LIGNIN; PHYTOESTROGEN; SECOISOLARICIRESINOL DIGLUCOSIDE;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CANCER INHIBITION; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC DISEASE; CLINICAL TRIAL; DIET THERAPY; DIETARY INTAKE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SAFETY; ENZYME ACTIVITY; ENZYME INHIBITION; FOOD COMPOSITION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; INFLAMMATION; LINSEED; MALIGNANT NEOPLASTIC DISEASE; METABOLIC SYNDROME X; METABOLITE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL VALUE; OXIDATIVE STRESS; PREGNANT WOMAN; PROSTATE HYPERTROPHY; REVIEW; RISK REDUCTION; ANIMAL; CHEMISTRY; DIABETES MELLITUS; DIET; FEMALE; FLAX; METABOLISM; NEOPLASM; PREGNANCY;

ANIMALIA; LINUM USITATISSIMUM; MAMMALIA;

ANIMALS; ANTIOXIDANTS; BUTYLENE GLYCOLS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DIET; ENZYME ACTIVATORS; ENZYME INHIBITORS; FEMALE; FLAX; GLUCOSIDES; HUMANS; LIGNIN; NEOPLASMS; PHYTOESTROGENS; PREGNANCY;

EID: 77951234112     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509992753     Document Type: Review

References (87)

1. Bloedon LT, Balikai S, Chittams J, et al. (2008) Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr 27, 65-74.
2. Lucas EA, Wild RD, Hammond LJ, et al. (2002) Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 87, 1527-1532.
3. Demark-Wahnefried W, Polascik TJ, George SL, et al. (2008) Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev 17, 3577-3587.
4. Jenab M & Thompson LU (1996) The influence of flaxseed and lignans on colon carcinogenesis and b-glucuronidase activity. Carcinogenesis 17, 1343-1348.
5. Diederichsen A (2006) Variation of mucilage in flax seed and its relationship with other seed characters. Crop Sci 46, 365-371.
6. Choo WS (2007) Physicochemical and quality characteristics of cold-pressed flaxseed oils. J Food Compost Anal 20, 202-211.
7. Johnsson P, Kamal-Eldin A, Lundgren LN, et al. (2000) HPLC method for analysis of secoisolariciresinol diglucoside in flaxseeds. J Agric Food Chem 48, 5216-5219.
8. Sicilia T, Niemeyer HB, Honig DM, et al. (2003) Identification and stereochemical characterization of lignans in flaxseed and pumpkin seeds. J Agric Food Chem 51, 1181-1188.
9. Zhang W, Wang X, Liu Y, et al. (2008) Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects. Br J Nutr 99, 1301-1309.
10. Kamal-Eldin A, Peerlkamp N, Johnsson P, et al. (2001) An oligomer from flaxseed composed of secoisolariciresinoldiglu-coside and 3-hydroxy-3-methyl glutaric acid residues. Phyto-chemistry 58, 587-590.
11. Luyengi L, Pezzuto JM, Waller DP, et al. (1993) Linusitamarin, a new phenylpropanoid glucoside from Linum usitatissimum. J Nat Prod 56, 2012-2015.
12. Li X, Yuan JP, Xu SP, et al. (2008) Separation and determination of secoisolariciresinol diglucoside oligomers and their hydrolysates in the flaxseed extract by high-performance liquid chromatography. J Chromatogr A 1185, 223-232.
13. Hu C, Yuan YV & Kitts DD (2007) Antioxidant activities of the flaxseed lignan secoisolariciresinol diglucoside, its aglycone secoisolariciresinol and the mammalian lignans enterodiol and enterolactone in vitro. Food Chem Toxicol 45, 2219-2227.
14. Dean B, Chang S, Doss GA, et al. (2004) Glucuronidation, oxidative metabolism, and bioactivation of enterolactone in rhesus monkeys. Arch Biochem Biophys 429, 244-251.
15. Adlercreutz H, van der Wildt J, Kinzel J, et al. (1995) Lignan and isoflavonoid conjugates in human urine. J Steroid Biochem Mol Biol 52, 97-103.
16. Carreau C, Flouriot G, Bennetau-Pelissero C, et al. (2008) Enterodiol and enterolactone, two major diet-derived polyphe-nol metabolites have different impact on ERa transcriptional activation in human breast cancer cells. J Steroid Biochem Mol Biol 110, 176-185.
17. Welshons WV, Murphy CS, Koch R, et al. (1987) Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol. Breast Cancer Res Treat 10, 169-175.
18. Wang C & Kurzer MS (1997) Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr Cancer 28, 236-247.
19. Sathyamoorthy N, Wang TT & Phang JM (1994) Stimulation of ps2 expression by diet-derived compounds. Cancer Res 54, 957-961.
20. Mueller SO, Simon S, Chae K, et al. (2004) Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor a (ERa) and ERb in human cells. Toxicol Sci 80, 14-25.
21. Kilkkinen A, Stumpf K, Pietinen P, et al. (2001) Determinants of serum enterolactone concentration. Am J Clin Nutr 73, 1094-1100.
22. Adlercreutz H, Fotsis T, Lampe J, et al. (1993) Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chroma-tography-mass spectrometry. Scand J Clin Lab Invest Suppl 215, 5-18.
23. Penttinen-Damdimopoulou PE, Power KA, Hurmerinta TT, et al. (2009) Dietary sources of lignans and isoflavones modulate responses to estradiol in estrogen reporter mice. Mol Nutr Food Res 53, 996-1006.
24. Penttinen P, Jaehrling J, Damdimopoulos AE, et al. (2007) Diet-derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator. Endocrinology 148, 4875-4886.
25. Prasad K (2000) Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int J Angiol 9, 220-225.
26. Zhang W, Wang X, Liu Y, et al. (2008) Effects of dietary flaxseed lignan extract on symptoms of benign prostatic hyper-plasia. J Med Food 11, 207-214.
27. Brooks JD & Thompson LU (2005) Mammalian lignans and genistein decrease the activities of aromatase and 17b-hydroxy-steroid dehydrogenase in MCF-7 cells. J Steroid Biochem Mol Biol 94, 461-467.
28. Adams LS & Chen S (2009) Phytochemicals for breast cancer prevention by targeting aromatase. Front Biosci 14, 3846-3863.
29. Juurlink BHJ (2001) Therapeutic potential of dietary phase 2 enzyme inducers in ameliorating diseases that have an underlying inflammatory component. Can J Physiol Pharmacol 79, 266-282.
30. Wang W, Liu LQ, Higuchi CM, et al. (1998) Induction of NADPH:quinone reductase by dietary phytoestrogens in colonic Colo205 cells. Biochem Pharmacol 56, 189-195.
31. O'Keefe JH, Carter MD & Lavie CJ (2009) Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach. Mayo Clin Proc 84, 741-757.
32. Mathieu P, Poirier P, Pibarot P, et al. (2009) Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 53, 577-584.
33. Prasad K (2008) Regression of hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Atherosclerosis 197, 34-42.
34. Prasad K (2005) Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed. Atherosclerosis 179, 269-275. (Pubitemid 40364620)
35. Prasad K (1999) Reduction of serum cholesterol and hyper-cholesterolemic atherosclerosis in rabbits by secoisolarici-resinol diglucoside isolated from flaxseed. Circulation 99, 1355-1362.
36. Prasad K (2009) Flax lignan complex slows down the progression of atherosclerosis in hyperlipidemic rabbits. J Cardiovasc Pharmacol Ther 14, 38-48.
37. Prasad K (2007) A study on regression of hypercholesterolemic atherosclerosis in rabbits by flax lignan complex. J Cardiovasc Pharmacol Ther 12, 304-313.
38. Prasad K, Mantha SV, Muir AD, et al. (1998) Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low a-linolenic acid. Atherosclerosis 136, 367-375.
39. Felmlee MA, Woo G, Simko E, et al. (2009) Effects of the flax-seed lignans secoisolariciresinol diglucoside and its aglycone on serum and hepatic lipids in hyperlipidaemic rats. Br J Nutr 102, 361-369.
40. Penumathsa SV, Koneru S, Thirunavukkarasu M, et al. (2007) Secoisolariciresinol diglucoside: relevance to angiogenesis and cardioprotection against ischemia-reperfusion injury. J Pharmacol Exp Ther 320, 951-959.
41. Penumathsa SV, Koneru S, Zhan L, et al. (2008) Secoiso-lariciresinol diglucoside induces neovascularization-mediated cardioprotection against ischemia-reperfusion injury in hyper-cholesterolemic myocardium. J Mol Cell Cardiol 44, 170-179.
42. Sano T, Oda E, Yamashita T, et al. (2003) Antithrombic and anti-atherogenic effects of partially defatted flaxseed meal using a laser-induced thrombosis test in apolipoprotein E and low-density lipoprotein receptor deficient mice. Blood Coagul Fibrinolysis 14, 707-712.
43. Jenkins DJA, Kendall CWC, Vidgen E, et al. (1999) Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and pro-gestin activity: a controlled crossover trial. Am J Clin Nutr 69, 395-402.
44. Vanharanta M, Voutilainen S, Lakka TA, et al. (1999) Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study. Lancet 354, 2112-2115.
45. Vanharanta M, Voutilainen S, Rissanen TH, et al. (2003) Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study. Arch Intern Med 163, 1099-1104.
46. Spence JD, Thornton T, Muir AD, et al. (2003) The effect of flax seed cultivars with differing content of a-linolenic acid and lignans on responses to mental stress. J Am Coll Nutr 22, 494-501.
47. Hallund J, Ravn-Haren G, Bugel S, et al. (2006) A lignan complex isolated from flaxseed does not affect plasma lipid concentrations or antioxidant capacity in healthy postmeno-pausal women. J Nutr 136, 112-116. (Pubitemid 43156494)
48. Hallund J, Tetens I, Bügel S, et al. (2008) The effect of a lignan complex isolated from flaxseed on inflammation markers in healthy postmenopausal women. Nutr Metab Cardiovasc Dis 18, 497-502.
49. Hallund J, Tetens I, Bugel S, et al. (2006) Daily consumption for six weeks of a lignan complex isolated from flaxseed does not affect endothelial function in healthy postmenopausal women. J Nutr 136, 2314-2318. (Pubitemid 44329988)
50. Cornish SM, Chilibeck PD, Paus-Jennsen L, et al. (2009) A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults. Appl Physiol Nutr Metab 34, 89-98.
51. Fukumitsu S, Aida K, Ueno N, et al. (2008) Flaxseed lignan attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in mice. Br J Nutr 100, 669-676.
52. Prasad K (2001) Secoisolariciresinol diglucoside from flaxseed delays the development of type 2 diabetes in Zucker rat. J Lab Clin Med 138, 32-39.
53. Pan A, Sun J, Chen Y, et al. (2007) Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS ONE 2, e1148.
54. Pan A, Demark-Wahnefried W, Ye X, et al. (2009) Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients. Br J Nutr 101, 1145-1149.
55. Li D, Yee JA, Thompson LU, et al. (1999) Dietary supplementation with secoisolariciresinol diglycoside (SDG) reduces experimental metastasis of melanoma cells in mice. Cancer Lett 142, 91-96.
56. Tan KP, Chen J, Ward WE, et al. (2004) Mammary gland morphogenesis is enhanced by exposure to flaxseed or its major lignan during suckling in rats. Exp Biol Med (Maywood) 229, 147-157.
57. Rickard SE, Yuan YV, Chen J, et al. (1999) Dose effects of flaxseed and its lignan on N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. Nutr Cancer 35, 50-57.
58. Tou JC & Thompson LU (1999) Exposure to flaxseed or its lignan component during different developmental stages influences rat mammary gland structures. Carcinogenesis 20, 1831-1835.
59. Ward WE, Jiang FO & Thompson LU (2000) Exposure to flaxseed or purified lignan during lactation influences rat mammary gland structures. Nutr Cancer 37, 187-192.
60. Chen J, Tan KP, Ward WE, et al. (2003) Exposure to flaxseed or its purified lignan during suckling inhibits chemically induced rat mammary tumorigenesis. Exp Biol Med (Maywood) 228, 951-958.
61. Rickard SE, Yuan YV & Thompson LU (2000) Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside. Cancer Lett 161, 47-55.
62. Zhang LY, Wang XL, Sun DX, et al. (2008) Regulation of zinc transporters by dietary flaxseed lignan in human breast cancer xenografts. Mol Biol Rep 35, 595-600.
63. Bergman Jungestrom M, Thompson LU & Dabrosin C (2007) Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin Cancer Res 13, 1061-1067.
64. Kilkkinen A, Virtamo J, Vartiainen E, et al. (2004) Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study. Int J Cancer 108, 277-280.
65. Chen LH, Fang J, Sun Z, et al. (2009) Enterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells. J Nutr 139, 653-659.
66. Chen LH, Fang J, Li H, et al. (2007) Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway. Mol Cancer Ther 6, 2581-2590.
67. Boccardo F, Lunardi G, Guglielmini P, et al. (2004) Serum enterolactone levels and the risk of breast cancer in women with palpable cysts. Eur J Cancer 40, 84-89.
68. Pietinen P, Stumpf K, Mannisto S, et al. (2001) Serum entero-lactone and risk of breast cancer: a case-control study in eastern Finland. Cancer Epidemiol Biomarkers Prev 10, 339-344.
69. Gil L, Siems W, Mazurek B, et al. (2006) Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic Res 40, 495-505.
70. Lang CA, Mills BJ, Lang HL, et al. (2002) High blood gluta-thione levels accompany excellent physical and mental health in women aged 60 to 103 years. J Lab Clin Med 140, 413-417.
71. Paravicini TM & Touyz RM (2008) NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31, Suppl. 2, S170-S180.
72. Bowler JV (2002) The concept of vascular cognitive impairment. J Neurol Sci 203-204, 11-15.
73. Christman JW, Blackwell TS & Juurlink BH (2000) Redox regulation of nuclear factor kB: therapeutic potential for attenuating inflammatory responses. Brain Pathol 10, 153-162.
74. Franceschi C (2007) Inflammaging as a major characteristic of old people: can it be prevented or cured? Nutr Rev 65, S173-S176.
75. Prasad K (1997) Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flax-seed. Mol Cell Biochem 168, 117-123.
76. Kitts DD, Yuan YV, Wijewickreme AN, et al. (1999) Anti-oxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem 202, 91-100.
77. Hosseinian FS, Muir AD, Westcott ND, et al. (2007) AAPH-mediated antioxidant reactions of secoisolariciresinol and SDG. Org Biomol Chem 5, 644-654.
78. Nourooz-Zadeh J (2008) Key issues in F2-isoprostane analysis. Biochem Soc Trans 36, 1060-1065.
79. Vanharanta M, Voutilainen S, Nurmi T, et al. (2002) Association between low serum enterolactone and increased plasma F2-isoprostanes, a measure of lipid peroxidation. Atherosclerosis 160, 465-469.
80. Hemmings SJ & Barker L (2004) The effects of dietary flaxseed on the Fischer 344 rat: I. Development, behaviour, toxicity and the activity of liver g-glutamyltranspeptidase. Cell Biochem Funct 22, 113-121.
81. Prasad K (2005) Effect of chronic administration of lignan complex isolated from flaxseed on the hemopoietic system. Mol Cell Biochem 270, 139-145. (Pubitemid 40425244)
82. Ward WE, Yuan YV, Cheung AM, et al. (2001) Exposure to purified lignan from flaxseed (Linum usitatissimum) alters bone development in female rats. Br J Nutr 86, 499-505.
83. Ward WE, Yuan YV, Cheung AM, et al. (2001) Exposure to flaxseed and its purified lignan reduces bone strength in young but not older male rats. J Toxicol Environ Health A 63, 53-65.
84. Collins TF, Sprando RL, Black TN, et al. (2003) Effects of flaxseed and defatted flaxseed meal on reproduction and development in rats. Food Chem Toxicol 41, 819-834.
85. Tou JCL, Chen J & Thompson LU (1998) Flaxseed and its lignan precursor, secoisolariciresinol diglycoside, affect pregnancy outcome and reproductive development in rats. J Nutr 128, 1861-1868.
86. Ward WE, Chen J & Thompson LU (2001) Exposure to flaxseed or its purified lignan during suckling only or continuously does not alter reproductive indices in male and female offspring. J Toxicol Environ Health A 64, 567-577.
87. Ogborn MR, Nitschmann E, Bankovic-Calic N, et al. (2006) Effects of flaxseed derivatives in experimental polycystic kidney disease vary with animal gender. Lipids 41, 1141-1149.